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Abstract
The chimeric oncoprotein NUP98-HOXA9 results from the t(7;11)(p15;p15) chromosomal translocation and is associated
with acute myeloid leukemia. It causes aberrant gene regulation and leukemic transformation through mechanisms that are
not fully understood. NUP98-HOXA9 consists of an N-terminal portion of the nucleoporin NUP98 that contains many FG
repeats fused to the DNA-binding homeodomain of HOXA9. We used a Cytotrap yeast two-hybrid assay to identify proteins
that interact with NUP98-HOXA9. We identified Dynein Light Chain 1 (DYNLT1), an integral 14 KDa protein subunit of the
large microtubule-based cytoplasmic dynein complex, as an interaction partner of NUP98-HOXA9. Binding was confirmed
by in vitro pull down and co-immunoprecipitation assays and the FG repeat region of NUP98-HOXA9 was shown to be
essential for the interaction. RNAi-mediated knockdown of DYNLT1 resulted in reduction of the ability of NUP98-HOXA9 to
activate transcription and also inhibited the ability of NUP98-HOXA9 to induce proliferation of primary human
hematopoietic CD34+ cells. DYNLT1 also showed a strong interaction with wild-type NUP98 and other nucleoporins
containing FG repeats. Immunofluorescence analysis showed that DYNLT1 localizes primarily to the nuclear periphery,
where it co-localizes with the nuclear pore complex, and to the cytoplasm. Deletion studies showed that the interactions of
the nucleoporins with DYNLT1 are dependent predominantly on the C-terminal half of the DYNLT1. These data show for the
first time that DYNLT1 interacts with nucleoporins and plays a role in the dysregulation of gene expression and induction of
hematopoietic cell proliferation by the leukemogenic nucleoporin fusion, NUP98-HOXA9.
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Introduction
The nucleoporin NUP98, a component of the nuclear pore
complex, is characterized by numerous FG (phenylalanine-glycine)
repeats and plays important roles in nucleocytoplasmic transport
[1,2]. The N-terminal half of NUP98 contains these FG repeats
that are crucial for its role in nucleocytoplasmic transport [1,3,4].
At least 28 chromosomal rearrangements affecting the NUP98
gene, have been reported in many hematopoietic malignancies,
particularly acute myeloid leukemia (AML) [5]. Notably, the N-
terminus containing the FG repeats is retained in all the oncogenic
fusion proteins resulting from NUP98 gene rearrangements. Of the
NUP98 fusion partners, 10 are homeodomain transcription
factors, including HOXA9 [5]. The best-characterized NUP98-
homeodomain fusion is NUP98-HOXA9
[6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]. NUP98 fusions in-
cluding NUP98-HOXA9 have been shown to induce aberrant
proliferation and to disrupt differentiation in both human and
mouse hematopoietic precursors [9,14,17,19,21,22]. Proteins that
interact with NUP98-HOXA9 and play a role in downstream
gene regulation and leukemic transformation have not been well
defined. We have previously shown that amino-terminal enhancer
of split (AES) interacts with NUP98-HOXA9 and cooperates with
it in transcriptional dysregulation and cell transformation [16].
NUP98-HOXA9 also interacts with CBP/p300, HDAC, and
CRM1, resulting in transcriptional activation, transcriptional
repression, and inhibition of nuclear export, respectively
[7,12,13,18,19,23,24].
This study was aimed at identifying other NUP98-HOXA9-
interacting proteins and determining their role in the dysregulation
of gene expression by NUP98-HOXA9. Traditional yeast two-
hybrid assays based on intranuclear transcriptional activation are
likely to show a high number of false positives because of the
transactivating properties of the FG repeat-rich N-terminus of
NUP98-HOXA9 [13,25]. On the other hand, the Cytotrap yeast
two-hybrid method is based on interactions occurring in the
cytoplasm and is not affected by the transactivating properties of
the bait protein. Using this technique, we identified DYNLT1, an
integral protein subunit of the large microtubule-based cytoplas-
mic dynein complex [26,27,28], as a novel interaction partner of
NUP98-HOXA9 that is important for the ability of NUP98-
HOXA9 to dysregulate gene transcription.
Materials and Methods
K562 cDNA Library and Plasmid Construction
A K562 cDNA library was constructed as described previously
[16]. Briefly, total RNA was isolated from 326106 K562 cells
(ATCC) using RNAaqueous Kit (Ambion) according to the
manufacturer’s instructions. PolyA RNA was purified using PolyA
Purist Kit (Ambion) from the total RNA (350 mg) according to the
manufacturer’s instructions. A total of 5 mg polyA RNA was
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recovered and a cDNA library was synthesized and subcloned into
pMYR XR vector using the Cytotrap XR library construction kit
(Stratagene). Control plasmids for the two-hybrid assay were
provided with the kit. The bait plasmid pSOS-HA-NUP98-
HOXA9 was constructed by subcloning HA-tagged NUP98-
HOXA9 in-frame from pcDNA-HA-NUP98-HOXA9 [12,16].
pGEX6P1-HA-NUP98-HOXA9 and pGEX6P1-HA-HOXA9
were constructed by subcloning from pcDNA-HA-NUP98-
HOXA9 and pcDNA-HA-HOXA9 [12]. pGEX6P1-DYNLT1
and pcDNA-DYNLT1 were constructed by subcloning PCR-
amplified DYNLT1 cDNA from pMYR-DYNLT1. NUP98-
HOXA9 deletion mutants, pGL4.11-KBTBD10, and full length
and deletion mutants of NUP62 and NUP153 are described
elsewhere [18,19,29]. pGEX6P1 expressing DYNLT1 N-terminus
or C-terminus, and pcDNA expressing DYNLT1 N-terminus or
C-terminus were subcloned from pGEX6P1-DYNLT1. All PCR
products were verified by DNA sequencing.
Cytotrap Yeast Two Hybrid Analysis
Cytotrap yeast two-hybrid analysis was carried out following the
manufacturer’s instructions. Briefly, the pMYR vectors containing
the K562 cDNA library and pSOS-HA-NUP98-HOXA9 were co-
transformed into the temperature sensitive cdc25H yeast strain,
plated into selective medium containing glucose as the carbon
source and incubated at room temperature till colonies appeared.
The colonies were replica-plated into positive selective medium
containing galactose as the carbon source and incubated at 37uC
till visible colonies appeared. Temperature resistant cdc25 yeast
colonies growing at 37uC were isolated, patched into new plates
containing selective media, grown, and replica plated again to
confirm the positive growth and eliminate false positives. Cells
from the patches were grown in liquid medium and pMYR vectors
containing the positive clones were isolated. The isolated plasmids
were transformed and amplified in E. coli and DNA was isolated.
The purified DNA was sequenced using primers on both sides of
the cDNA insert regions. The cDNA inserts were identified using
the National Center for Biotechnology Information blast applica-
tion (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Recombinant Proteins
Glutathione S-transferase (GST), as well as GST-tagged HA-
NUP98-HOXA9, HOXA9, and DYNLT1 were produced from
the pGEX-6P1 vector in E. coli BL21 (DE3) bacteria and purified
using glutathione-Sepharose 4B beads (GE Healthcare). Recom-
binant DYNLT1 was isolated by digestion with Pre-Scission
protease (GE Healthcare).
Protein Binding Assays
Full length NUP98, NUP98-HOXA9 and its deletion mutants,
as well as full length NUP62 and NUP153 and their deletion
mutants, were produced using the TnT T7 quick coupled
transcription/translation system (Promega) in the presence of
Tran35S-label (MP Biomedicals). Protein binding assays were
carried out as described previously [29]. Briefly, for a binding
reaction, 10 ml of beads of immobilized recombinant protein (GST
control, or GST- DYNLT1, or GST- DYNLT1 N or C terminus)
were incubated for 1 h at 4uC with 34 ml of a mixture consisting of
in vitro translated protein, transport buffer-Tween 20 (TB-T, which
consists of 20 mm HEPES-KOH, pH 7.4, 110 mm potassium
acetate, and 2 mm MgCl2 with 0.1% Tween 20) and 0.5 mg/ml
Pefabloc (Roche). The unbound fraction was removed and the
beads were washed three times in cold TB-T. One fourth of the
unbound and all of the bound fractions were visualized by SDS-
PAGE and autoradiography.
For binding assays using all recombinant proteins, purified
recombinant DYNLT1 was incubated with immobilized GST,
GST-NUP98-HOXA9, or GST-HOXA9 proteins in 34 ml
mixtures in TB-T and processed as described above. Bands were
visualized by staining with Coomassie blue.
DYNLT1 Antibody Preparation
Recombinant DYNLT1 protein was purified as described above
and was submitted to Harlan Laboratories where rabbit immu-
nizations and bleedings were done according to their standard
Table 1. Non-specific and DYNLT1-specific shRNA/siRNA
sequences.
Target Company shRNA Sequence
Non-Specific Origene GCACTACCAGAGCTAACTCAGATAGTACT
Human DYNLT1 Origene GCTGGATTACACACAGCAAGTTCCTGCTT
Human DYNLT1 Origene GGTGGTAACGCTTATCAACACAGCAAAGT
siRNA Sequence
Non-specific Invitrogen Not provided
Human DYNLT1 Invitrogen CAAAGTGAACCAGTGGACCACAAAT
Human DYNLT1 Invitrogen GAACAAACTTTAAGCCAACTCACCA
Human DYNLT1 Invitrogen TCAGTGCCTTCGGACTGTCTATTTG
doi:10.1371/journal.pone.0067032.t001 Figure 1. Cytoplasmic yeast two-hybrid analysis identifies
DYNLT1 as an interacting partner for NUP98-HOXA9. K562
cDNA library in pMyr vector was co-transformed with pSOS-NUP98-
HOXA9 into cdc25H yeast strain. Isolated colonies were patched on
galactose-containing medium and transferred to 37uC. Patches growing
at 37uC were re-spotted on plates containing selective medium
supplemented with either glucose (repressing) or galactose (de-
repressing) as sole carbon source and incubated either at 23uC
(permissive) or 37uC (restrictive) for 3–5 days. Plasmids were isolated
from yeast cells growing at 37uC in galactose containing medium and
retransformed along with pSOS-NUP98-HOXA9 to confirm the interac-
tions. Several positive cDNA clones were sequenced and identified as
DYNLT1. Cells containing pSOS-NUP98-HOXA9 with pMYR-LaminC or
empty pSOS vector with pMyr-DYNLT1 were spotted as negative
controls. Cells containing pSOS-NUP98-HOXA9 with pMYR-SB (SOS
Binding protein) were spotted as a positive control. Growth at 37uC in
galactose containing medium indicates a positive interaction.
doi:10.1371/journal.pone.0067032.g001
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protocols. Production bleeds with the highest concentration of
DYNLT1 antibody as detected by immunoblotting on K562 cell
lysate and purified DYNLT1 were selected for antibody purifica-
tion. At each step of purification, serum and antibody fractions
were tested by immunoblotting of K562 cell lysate (Fig. S1).
Samples were subjected to SDS-PAGE and transferred to PVDF
membranes. Membrane strips were prepared and incubated with
dilutions of pre-bleed serum, test bleeds, production bleeds,
samples from different stages of purification and collected fractions
(Fig. S1). An HRP-conjugated anti-rabbit antibody was used as
secondary antibody. Antiserum (Fig. S1, lane 1) was first
precleared for 4 h at 4uC using 1 ml Affigel 15 beads (Bio-Rad)
loaded with lysate containing 30 mg protein from E. coli BL21
bacteria expressing empty pGEX6P1 vector (Fig. S1, lane 2). The
pre-cleared serum was added to a column containing 1 ml Affigel
15 beads loaded with 1 mg DYNLT1 protein and incubated
overnight with rotation at 4uC. The flow-through fraction was
depleted of DYNLT1 antibody as shown in Fig. S1, lane 3. The
column was washed 6 times with 10 ml cold DPBS at 4uC. Bound
antibody was eluted once with 4 ml 1 M NaCl in DPBS, once with
4 ml 0.1 M Glycine, pH 2.5 and once with 4 ml 0.1 M Glycine
pH 2.5, 1 M NaCl, 1% CHAPS. For each elution, 0.5 ml
fractions were collected, and glycine-containing fractions were
neutralized with 25 ml of 1 M Tris-base. Antibody concentration
in the various fractions was determined by Amido Black staining
and immunoblotting of purified recombinant DYNLT1 or K562
lysate (Fig. S1, lanes 4–11). More than 90% of the antibody was
detected in fractions 4, 5 and 6 of the 0.1 M Glycine pH 2.5
elution (Fig. S1, lanes 7–9); these fractions were stored at 280uC.
Specificities of the antibodies were determined by immunobloting
either purified recombinant proteins or K562 lysates. To further
test the anti-DYNLT1 antibody, K562 cells were nucleofected
with empty pRFP-C-RS vector, vector containing nonspecific
shRNA, or vectors containing two different shRNAs against
DYNLT1 (Origene) (see Table 1 for sequences). Lysates were
subjected to SDS-PAGE and DYNLT1 was detected with the anti-
DYNLT1 antibody.
Figure 2. DYNLT1 interacts with NUP98-HOXA9 in vitro and in vivo. A) GST, GST-NUP98-HOXA9, or GST-HOXA9 were immobilized on beads
and incubated with purified recombinant DYNLT1 protein. The samples were subjected to SDS-PAGE and coomassie stained. B) Co-
immunoprecipitation of NUP98-HOXA9 with DYNLT1 in K562 cells transfected with HA-NUP98-HOXA9. Whole cell lysates were subjected to
immunoprecipitation with either rabbit IgG or anti-DYNLT1 antibody. NUP98-HOXA9 in the cell lysates (Input) and immunoprecipitated complexes
(IP) was detected by immunoblotting with anti-HA antibody. DYNLT1 was detected by immunoblotting with anti-DYNLT1 antibody. C) Densitometric
quantification of immunoprecipitated NUP98-HOXA9 with control IgG or anti-DYNLT1 antibody.
doi:10.1371/journal.pone.0067032.g002
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Immunofluorescence Microscopy
For localization of DYNLT1, 25,000 HEPG2 (ATCC) cells
were grown overnight on poly-L- lysine coated coverslips
(Neuvitro), fixed with methanol/1mM EGTA for 10 min at
220uC, washed with PBS twice, and blocked with 2% normal
goat serum in DPBS with 1% BSA, 0.1% Tween 20. Primary
antibodies used were rabbit anti-DYNLT1 along with mouse MAb
414 (Abcam). The fluorescent secondary antibodies used were
FITC-conjugated anti-rabbit IgG from goat (Santa Cruz Biotech-
nology) and rhodamine-conjugated anti-mouse IgG from goat
(Millipore Corp.). The slides were mounted with Vectashield
mounting medium with DAPI (Vector Laboratories). The images
were captured using an Eclipse 80i fluorescent microscope (Nikon)
and processed in Metamorph ver 6.3r2 software (Molecular
Devices).
Co-immunoprecipitation
For DYNLT1 immunoprecipitation with NUP98-HOXA9, 107
K562 cells were nucleofected with pcDNA-HA-NUP98-HOXA9
using a Nucleofector device (Lonza). The co-immunoprecipita-
tions of NUP62 or NUP153 or NUP98 with DYNLT1 were done
in untransfected K562 cells as described previously [16]. Briefly,
cells were harvested 16 h post nucleofection, washed with cold
DPBS, and lysed for 30 min on ice with 0.5 ml of lysis buffer
(10 mM Tris pH 7.5, 0.4 M NaCl, 0.4% Triton X-100, 1% NP-
40, 0.2% sodium deoxycholate, 1 mM EDTA, protease inhibitors
(Roche), 1 mM PMSF). Dilution buffer (10 mM Tris pH 7.5,
1 mM EDTA, 1 mM PMSF, protease inhibitors) (0.5 ml) was
added to the lysate, followed by centrifugation at 17,0006g for
30 min at 4uC. The supernatants were transferred to new tubes
and either rabbit IgG or rabbit anti-DYNLT1 antibody was
added. After overnight incubation at 4uC, 30 ml Protein G beads
were added and incubated for another 1 h. Beads were washed
with 700 ml of wash buffer (10 mM Tris pH 7.5, 1 mM EDTA,
0.2 M NaCl, 0.2% Triton X-100, 0.5% NP-40, 0.1% sodium
deoxycholate, 1 mM PMSF, 1X protease inhibitors) 5 times,
3 min each time, followed by centrifugation at 18006g for 3 min
at 4uC. Beads were washed with cold DPBS and bound proteins
were eluted by boiling with 30 ml of 2X SDS buffer (0.1 M Tris
pH 6.8, 10% Glycerol, 3.5% SDS, 2 mM DTT, 0.004%
Bromophenol Blue) for 10 min. Input lysates and immunoprecip-
itated proteins were subjected to SDS-PAGE (7.5% gel) followed
by immunoblotting. NUP98-HOXA9 was detected with an anti-
HA antibody; NUP98 with anti-NUP98 antibody (Cell Signaling
Technology); NUP62 or NUP153 with mouse MAb414 antibody.
Figure 3. DYNLT1 interacts with the FG repeat region of NUP98-HOXA9. A) Full length NUP98, NUP98-HOXA9 and NUP98-HOXA9 deletion
mutants. Vertical lines represent FG repeats. DBD=DNA-binding domain. B) GST or GST-DYNLT1 were immobilized on beads and incubated with
in vitro translated full length NUP98, NUP98-HOXA9, or deletion mutants of NUP98-HOXA9. Bound and unbound fractions were resolved by SDS-
PAGE and subjected to autoradiography.
doi:10.1371/journal.pone.0067032.g003
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Luciferase Assay
For analysis for DYNLT1 deletion mutants, K562 cells were
nucleofected with 5 mg pGL4.11 vector driven by the KBTBD10
promoter and 10 mg pcDNA-HA-NUP98-HOXA9 in combina-
tion with 10 mg of empty pcDNA3, pcDNA-DYNLT1, pcDNA-
DYNLT1 N-terminus, or pcDNA-DYNLT1 C-terminus. For
shRNA-mediated knockdown of DYNLT1, K562 cells were
nucleofected with 5 mg pGL4.11 vector driven by the KBTBD10
promoter in combination with 10 mg of either empty pcDNA3, or
pcDNA3 expressing HA-NUP98-HOXA9. In addition, either
empty pRFP-C-RS vector (Origene-TR30014), vector containing
non-specific shRNA (Origene-TR30015), or vectors containing
two different shRNA against DYNLT1 (Origene-TF313329) were
included (Table 1). Knockdown of DYNLT1 was confirmed by
immunoblotting with the anti-DYNLT1 antibody and the
efficiency of knockdown was measured by densitometric analysis
(Fig. S2). To control for efficiency of transfection, 0.5 mg of pRL-
TK (Promega), which expresses Renilla luciferase was included.
Five million cells were incubated with the DNA at room
temperature for 10 min before electroporation and 10 min after
electroporation, and were cultured in 10 ml IMDM media with
10% FBS, 2 mM L-glutamine, and 100 units/ml penicillin/
streptomycin. Luciferase activity was measured 48 h after electro-
poration using the Dual Luciferase Reporter Assay System
(Promega) and the results were normalized to Renilla luciferase.
Retroviral Transduction and Primary Human CD34+ Cells
Proliferation Assay
Frozen human CD34+ cells from healthy volunteers (Fred
Hutchinson Cancer Research Center) were prestimulated and
transduced with MSCV-IRES-YFP retrovirus expressing HA-
NUP98-HOXA9 as previously described [17]. After 48 h, YFP
positive cells were isolated using a MoFlo high-speed sorter (Dako)
and expression of the NUP98-HOXA9 was confirmed by
immunoblotting with anti-HOXA9 antibody. For DYNLT1
knockdown, NUP98-HOXA9 transfected CD34+ cells were
grown for two weeks and nucleofected with either non-specific
siRNA (Invitrogen-12935-300) or siRNA specific for DYNLT1
(Invitrogen-1299003) (Table 1). An MTS cell proliferation assay
was done using CellTiter 96H AQueous NonRadioactive Cell
Proliferation Assay (Promega G5421) according to the manufac-
turer’s instructions. Twenty five thousand transfected cells were
seeded into a 96-well plate in triplicate and grown for 24 h, 48 h
and 72 h in 100 ml of culture medium. Twenty ml of MTS/
phenazine methosulfate solution was added and the cells were
incubated at 37uC for 2 h. The absorbance at 490 nm was
measured using an ELISA plate reader. Knockdown of DYNLT1
was confirmed by immunoblotting using the anti-DYNLT1
antibody.
Figure 4. DYNLT1 localizes to the cytoplasm and the nuclear periphery. HEPG2 cells were grown on a coverslip and permeabilized with
methanol. Cells were immunostained with the anti-DYNLT1 (green) antibody together with MAb414 (red) that marks the nuclear periphery by
staining nucleoporins. The nuclei were counterstained with DAPI. Scale bar = 50 mm.
doi:10.1371/journal.pone.0067032.g004
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Results
Cytotrap Two-hybrid Analysis shows that NUP98-HOXA9
Interacts with Dynein Light Chain 1 (DYNLT1)
We used a Cytotrap yeast two-hybrid assay to identify possible
interaction partners of the oncoprotein NUP98-HOXA9. The
traditional two-hybrid assay is based on intranuclear interactions
and is likely to show many false positives when the bait contains a
transactivation domain such as the N-terminus of NUP98-
HOXA9 [13]. In the Cytotrap yeast two-hybrid assay, the cDNA
library expressing the target genes is subcloned downstream of a
myristylation signal that localizes the proteins to the plasma
membrane and the bait protein is fused to hSOS which remains in
the cytoplasm. A physical interaction between the bait protein and
one of the cDNA targets, results in recruitment of the hSOS
protein to the plasma membrane, which causes activation of the
Ras signaling pathway. This allows the cdc25H strain to grow and
form colonies at the restrictive temperature (37uC) in galactose-
containing medium. The bait protein was prepared by fusing
NUP98-HOXA9 to hSOS and the target cDNA library was
prepared from human K562 cells and subcloned into the pMYR
vector. Expression of hSOS-NUP98-HOXA9 in the cdc25H yeast
strain was confirmed by immunoblotting [16]. Controls for the
assay were performed according to manufacturer’s instructions as
previously described [16]. The cdc25H heat-sensitive yeast strain
was transformed with both the bait protein and the target cDNA
library. Several hundred colonies appeared and were replica-
plated onto galactose-containing medium to induce expression of
the target library. Colonies growing on the galactose-containing
medium were isolated and selection in stringent temperature and
media was repeated for selection of true positive clones. The
cDNA inserts from the positive clones were isolated and
sequenced. Several of the positive clones encoded full length
Dynein Light Chain 1 (DYNLT1).
To confirm the interaction between NUP98-HOXA9 and
DYNLT1, the plasmids encoding DYNLT1 along with either
pSOS vector or vector expressing hSOS-NUP98-HOXA9 were
reintroduced into the cdc25H yeast strain. Colonies were isolated
and patched into positive selective medium and subjected to the
restrictive temperature. Co-transfection of with the pSOS-NUP98-
HOXA9 bait construct along with a plasmid expressing
myristylated Lamin C into cdc25 strain served as the negative
control. Cells co-transfected with the pSOS-NUP98-HOXA9 bait
construct and a plasmid expressing myristylated SOS-binding
protein (SB) served as the positive control. As shown in Fig. 1
growth was observed in all transformants incubated at 23uC. No
Figure 5. DYNLT1 interacts with FG repeat regions of NUP153 and NUP62. A) Full length NUP153, NUP153 deletion mutants, NUP62 and
NUP62 deletion mutants. Vertical lines represent FG repeats. B) GST or GST-DYNLT1 immobilized on beads were incubated with in vitro translated
NUP153, NUP62, or their deletion mutants. Bound and unbound fractions were resolved by SDS-PAGE and subjected to autoradiography. C) Co-
immunoprecipitation of NUP153, NUP62 and NUP98 with DYNLT1 in K562 cells. Whole cell lysates were subjected to immunoprecipitation with either
rabbit IgG or anti-DYNLT1 antibody. Both input and immunoprecipitates (IP) were probed for NUP153 or NUP62 using the MAb414 antibody or
NUP98 using anti-NUP98 antibody. DYNLT1 was detected with anti-DYNLT1 antibody.
doi:10.1371/journal.pone.0067032.g005
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growth was observed at 37uC in glucose containing medium
because the cDNA library is cloned under a galactose-inducible
promoter and was not expressed in the absence of galactose. When
transferred to restrictive 37uC, no growth was seen in cells co-
expressing pMYR-LaminC and pSOS-NUP98-HOXA9 indicat-
ing that NUP98-HOXA9 does not activate Ras signaling by
targeting itself to the plasma membrane. Growth was present in
cells co-expressing myristylated SB (SOS binding protein) and
pSOS-NUP98-HOXA9 because the membrane-anchored SB
protein recruits hSOS-NUP98-HOXA9 to the plasma membrane
by binding to the hSOS portion. Cells co-transfected with hSOS-
NUP98-HOXA9 and DYNLT1 showed a similar growth pattern
suggesting a specific interaction between DYNLT1 and NUP98-
HOXA9. The positive interaction observed with hSOS-NUP98-
HOXA9 is not due to binding of DYNLT1 to the hSOS portion of
the bait as there was no growth in cells transfected with the empty
hSOS vector and DYNLT1 (Fig. 1).
DYNLT1 Interacts with the FG Repeat Region of NUP98-
HOXA9
To establish a direct interaction between DYNLT1 and
NUP98-HOXA9 an in-vitro binding assay was carried out using
purified recombinant proteins. GST, GST-NUP98-HOXA9, or
GST-HOXA9 were immobilized on beads and incubated with
purified DYNLT1 protein. As shown in Fig. 2A, GST-NUP98-
HOXA9 interacted with DYNLT1 whereas no interaction was
observed for GST or GST-HOXA9. This suggests that DYNLT1
specifically interacts with the NUP98 portion of the NUP98-
HOXA9 fusion protein.
To demonstrate that NUP98-HOXA9 interacts with DYNLT1
in vivo, co-immunoprecipitation was carried out using K562 cells
transfected with HA-tagged NUP98-HOXA9. As the affinity and
specificity of the commercially available DYNLT1 antibody were
not optimal (data not shown), a rabbit polyclonal antibody was
raised (Fig. S1) and used for immunoprecipitation. Whole cell
lysates were subjected to immunoprecipitation with either rabbit
Figure 6. C-terminus of DYNLT1 interacts with NUP98-HOXA9, NUP62 and NUP153. A) Full length DYNLT1 and deletion mutants. B) GST or
GST-DYNLT1 or GST-DYNLT1 N-terminus or GST-DYNLT1 C-terminus with in vitro translated NUP98-HOXA9, NUP62 or NUP153. Bound and unbound
fractions were resolved by SDS-PAGE and subjected to autoradiography. C) K562 cells were nucleofected with pGL4.11 vector driven by the KBTBD10
promoter and pcDNA-HA-NUP98-HOXA9 in combination with either empty pcDNA3, pcDNA-DYNLT1, pcDNA-DYNLT1 N-terminus, or pcDNA-DYNLT1
C-terminus. Firefly luciferase activity was measured 48 hours after transfection and normalized to a Renilla luciferase internal control. The numbers
represent fold change over control (average of 3 independent experiments); error bars represent standard deviations. The P values indicated were
obtained by a two-tailed t-test in comparison to NUP98-HOXA9 alone.
doi:10.1371/journal.pone.0067032.g006
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IgG or anti-DYNLT1 antibody and probed for NUP98-HOXA9
with anti-HA antibody. As shown in Figs. 2B and 2C, NUP98-
HOXA9 co-immunoprecipitated with endogenous DYNLT1,
confirming their interaction within human myeloid cells.
To define essential regions in NUP98-HOXA9 responsible for
the interaction with DYNLT1, GST-DYNLT1 was immobilized
on beads and incubated with in-vitro translated full length NUP98,
NUP98-HOXA9, or deletion mutants of the NUP98 portion of
NUP98-HOXA9. The NUP98-HOXA9 mutants were deleted for
the N-terminus (D1–253), C-terminus (D253–445) or the entire
NUP98 portion (D1–469) (Fig. 3A). DYNLT1 interacted with full
length NUP98 and NUP98-HOXA9 to a similar extent (Fig. 3B).
Removal of the C-terminal portion of the NUP98 moiety (D253–
445) did not affect binding of NUP98-HOXA9 to DYNLT1. On
the other hand, when the N-terminal of NUP98-HOXA9 was
deleted (D1–253), the interaction was significantly reduced. The
interaction of DYNLT1 with NUP98-HOXA9 was abolished by
deletion of the entire NUP98 moiety (Fig. 3B). These data show
that DYNLT1 interacts with the FG repeat-rich NUP98 moiety of
NUP98-HOXA9 and that the first 253 amino acids of NUP98-
HOXA9 are required for optimal interaction with DYNLT1.
DYNLT1 Colocalizes with the Nuclear Pore Complex
DYNLT1, also known as Tctex-1, is an integral 14 KDa protein
subunit of the large microtubule-based cytoplasmic dynein
complex [26,27,28]. The interaction of DYNLT1 with the FG
repeat region of NUP98-HOXA9 suggests that DYNLT1 may
interact with other FG repeat nucleoporins and localize to the
nuclear pore complex. To determine the intracellular localization
of DYNLT1 in relation to the nuclear pore complex, human
HEPG2 cells were immunostained with rabbit anti-DYNLT1 and
mouse MAb414 that highlights the nuclear pore complexes [30]. A
FITC-conjugated anti-rabbit secondary antibody was used to
detect DYNLT1 and a rhodamine-conjugated anti-mouse sec-
ondary antibody was used to highlight the nucleoporins. DYNLT1
was found throughout the cell and formed a ring around the
nuclear periphery where it co-localized with the nuclear pore
complexes (Fig. 4).
DYNLT1 Interacts with FG Repeat Nucleoporins
The immunolocalization of DYNLT1 to the nuclear rim and its
binding to the FG repeat portion of NUP98 raised the possibility
that DYNLT1 interacts with other FG repeat nucleoporins. To
determine whether this is the case, GST-DYNLT1 immobilized
on beads was incubated with in vitro translated NUP153, NUP62,
or their deletion mutants (Fig. 5A). As shown in Fig. 5B, DYNLT1
interacts with both NUP153 and NUP62. The binding of
DYNLT1 to NUP153 was mildly diminished by deletion of either
the N- or C-terminus. On the other hand, removal of the FG-
repeat containing N-terminus of NUP62 almost completely
abolished the interaction with DYNLT1.
To confirm that DYNLT1 interacts with nucleoporins in vivo,
K562 cell lysates were subjected to immunoprecipitation with
either rabbit IgG or anti-DYNLT1 antibody and probed for
NUP153 and NUP62 using the mouse MAb414 antibody and for
NUP98 using the rabbit anti-NUP98 antibody. As shown in
Fig. 5C, DYNLT1 coimmunoprecipitates with NUP153, NUP62
and NUP98.
To identify DYNLT1 domains that interact with NUP98-
HOXA9 and nucleoporins, either GST, or GST fused to
DYNLT1, DYNLT1 N-terminus (aa 1–61), or DYNLT1 C-
terminus (aa 62–113) (Fig. 6A) were immobilized on beads. Pull
down assays were performed with in-vitro translated NUP98-
HOXA9, NUP62, or NUP153. As shown in Fig. 6B, the C-
terminus of DYNLT1 showed weak interactions with NUP98-
HOXA9 as well as nucleoporins NUP62 and NUP153, whereas
the N-terminus of DYNLT1 showed no such interactions. Both
the N-terminus and the C-terminus were needed for optimal
interactions with NUP98-HOXA9, NUP62, and NUP153.
To test whether the DYNLT1 C-terminus, that interacts with
NUP98-HOXA9 plays a role in transcriptional dysregulation by
NUP98-HOXA9, a luciferase reporter construct driven by the
KBTBD10 promoter was introduced into K562 cells along with a
construct expressing NUP98-HOXA9 in combination with full
length DYNLT1 or DYNLT1 N-terminus or C-terminus.
Overexpression of the full length DYNLT1 or the DYNLT1 C-
terminus resulted in a significant increase in transcriptional
activation of the reporter construct by NUP98-HOXA9, whereas
Figure 7. shRNA mediated knockdown of DYNLT1 inhibits
downstream gene regulation by NUP98-HOXA9. K562 cells were
transfected with a firefly luciferase construct driven by the KBTBD10
promoter with either empty vector or vector expressing NUP98-HOXA9.
In addition, the transfections included either empty vector, or vector
expressing non-specific shRNA, or 2 vectors expressing different
DYNLT1 shRNAs. Firefly luciferase activity was measured 48 hours after
transfection and normalized to a Renilla luciferase internal control. The
numbers represent fold change over control (average of 3 independent
experiments); error bars represent standard deviations. The P value
indicated was obtained by a two-tailed t-test. The knockdown of
DYNLT1 were verified by immunoblotting with anti-HA or anti-DYNLT1
antibody.
doi:10.1371/journal.pone.0067032.g007
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overexpression of the DYNLT1 N-terminus did not result in
increased transcriptional activity by NUP98-HOXA9 (Fig. 6C).
DYNLT1 is Required for Transcriptional Activation by
NUP98-HOXA9
NUP98-HOXA9 causes transcriptional dysregulation in human
hematopoietic cells [12,13,17,19]. In the human myeloid K562
cell line, we have previously identified the KBTBD10 gene as a
direct transcriptional target of NUP98-HOXA9 [19]. To test
whether DYNLT1 plays a role in transcriptional dysregulation by
NUP98-HOXA9, DYNLT1 was knocked down using two
different anti-DYNLT1 shRNA constructs. A luciferase reporter
construct driven by the KBTBD10 promoter was introduced into
K562 cells along with a construct expressing NUP98-HOXA9,
with or without non-specific shRNA or one of the two DYNLT1-
specific shRNA constructs. Knockdown of DYNLT1 was
confirmed by immunoblotting (Figs. 7 and S2). Interestingly,
knockdown of DYNLT1 by either of the shRNA constructs
resulted in impairment of transcriptional activation of the
KBTBD10 promoter by NUP98-HOXA9 (Fig. 7). No such
impairment of transcriptional activation was observed with the
non-specific shRNA construct. This indicates that DYNLT1 plays
a role in transcriptional dysregulation by NUP98-HOXA9 and
raises the possibility that DYNLT1 plays a role in the leukemo-
genic effects of NUP98-HOXA9.
Knockdown of DYNLT1 Inhibits NUP98-HOXA9 Mediated
Proliferation of Primary Human CD34+ Cells
To demonstrate the role of DYNLT1 in NUP98-HOXA9-
mediated aberrant cell proliferation, human CD34+ primary cells
were retrovirally transduced to express NUP98-HOXA9 from an
MSCV-IRES-YFP vector. Transduced cells were isolated by
sorting for YFP positivity, and expression of NUP98-HOXA9 was
confirmed by immunoblotting (Fig. 8A). CD34+ cells expressing
NUP98-HOXA9 were transfected with either nonspecific siRNA
or DYNLT1 siRNA and were grown for 24 h, 48 h and 72 h and
knockdown of DYNLT1 was confirmed by immunoblotting with
anti-DYNLT1 antibody (Fig. 8B). An MTS cell proliferation assay
was performed and showed that knockdown of DYNLT1 resulted
in a significant inhibition of cell proliferation at 48 h and 72 h
(Fig. 8C). These data suggest that DYNLT1 plays a role in the
transformation of human hematopoietic cells by NUP98-HOXA9.
Discussion
DYNLT1 is an integral 14 KDa protein subunit of the large
microtubule-based cytoplasmic dynein complex [26,27,28]. There
are four major subunits of this complex namely, the ,530 KDa
heavy chains (HC), ,74 KDa intermediate chains (IC), ,33–
59 KDa intermediate light chains (ILC) and the ,10–14 KDa
light chains (LC) [31,32,33]. Three families of Dynein light chains
have been identified: the t-complex–associated family (DYNLT1,
DYNLT3), the Roadblock family (DYNLRB1, DYNLRB2), and
Figure 8. Knockdown of DYNLT1 inhibits proliferation of cells expressing NUP98-HOXA9. A) Primary human CD34+ cells were retrovirally
transduced with either control MSCV-IRES-YFP vector or vector expressing NUP98-HOXA9. Cells positive for YFP were sorted and NUP98-HOXA9 was
detected by immunoblotting with an anti-HOXA9 antibody; immunoblotting for actin was used as a loading control. B) Knockdown of DYNLT1 was
confirmed by immunoblotting with the anti-DYNLT1 antibody; actin immunoblotting was used as a loading control.C) Sorted NUP98-HOXA9-
expressing human primary CD34+ cells were transfected by nucleofection with non-specific siRNA and siRNA specific for DYNLT1. Cells were seeded
into a 96-well plate in triplicate and cell proliferation was measured 24 h, 48 h and 72 h later by an MTS assay using CellTiter 96H AQueous
Nonradioactive Cell Proliferation Assay. The y axis represents cell proliferation as measured by the absorbance at 490 nm. The error bars represent
standard deviation from three independent experiments; the p-values were calculated using a two-tailed t-test.
doi:10.1371/journal.pone.0067032.g008
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the LC8 family (DYNLL1, DYNLL2) [33]. The two DYNLT1
polypeptides within the cytoplasmic dynein complex form
homodimers and also interact with the N-terminus of the
intermediate chain DYNC1I1 [34,35,36]. The dynein complex
is involved in a variety of cellular functions including transport of
membranous organelles, mitotic spindle orientation, nuclear
migration, and cell migration [37]. Dynactin is part of an actin-
related cytoplasmic protein complex that interacts with Dynein
and is essential for its function [38,39,40].
In yeast, dynein light chain (Dyn2) localizes to the nuclear pore
complex through its interaction with the FG repeat-containing
nucleoporin Nup159, and it has been suggested that Dyn2 may
play a role in organizing the natively unfolded FG repeats within
the nuclear pore complex and promoting oligomerization of
nucleoporin subcomplexes [41,42]. There is evidence that
ubiquitylation of NUP159 is necessary for recruitment of Dyn2
to the nuclear pore complex and this interaction facilitates the
migration of nuclei to daughter cells during mitosis [43].
Homology search using the Saccharomyces Genome Database
(SGD) http://www.yeastgenome.org/showed that yeast Dyn2
protein shares homology with both human DYNLL1 (50%) and
DYNLL2 (47%) but not with DYNLT1.
In higher eukaryotes, several reports have shown evidence for
an association between dynein and the nuclear envelope and/or
the nuclear pore complex. These associations mostly occur during
mitosis and are generally indirect. For example, in mammalian
cells dynein intermediate chains have been localized to the nuclear
envelope during prophase [44,45]. Similarly, in Drosophila,
dynein mediates the attachment of centrosomes to the nuclear
envelope during mitosis [46]. Payne et al. showed that several
nucleoporins coimmunoprecipitate with dynactin in the mamma-
lian zygote; they suggested that the interaction between nucleo-
porins and dynactin is indirect and is mediated by vimentin [47]. It
has also been shown in mammalian cells that dynein is recruited to
the nuclear pore complex during the G2 phase through an
interaction between the adaptor molecule, BICD2 and the
nucleoporin RANBP2 (NUP358) [48]. Dynein light chain
DYNLL1 and dynactin have also been shown to co-immunopre-
cipitate with the nucleoporin TPR in HeLa cells during mitosis
[49]. The interaction with dynein was confirmed by pulldown
assays using TPR prepared in a reticulocyte lysate system; however
since the latter contains cellular proteins, it remains unclear
whether the interaction is direct. A recent study has shown that
during prophase the nucleoporin NUP133 anchors the dynein/
dynactin complex to the nuclear envelope indirectly through
interactions with CENP-F and NudE/EL [50]. Thus it appears
that dynein interacts transiently and indirectly with components of
the nuclear pore complex to facilitate cell division.
In contrast, the data presented here demonstrate, for the first
time to our knowledge, that a cytoplasmic dynein component
directly interacts with nucleoporins in mammalian cells and that
the interaction occurs in interphase. We have shown that
DYNLT1 co-localizes with the nuclear pore complex and binds
to the nucleoporins NUP98, NUP62 and NUP153 as well as to the
oncogenic nucleoporin fusion NUP98-HOXA9. All of these
DYNLT1-interacting nucleoporins contain the highly conserved
FG repeat regions [1]. In the case of NUP62 and NUP98-HOXA9
these FG repeat regions are required for binding to DYNLT1
(Figs. 3 and 5).
The function of DYNLT1 at the nuclear pore complex remains
to be determined. One possibility is that it may have a function in
nucleocytoplasmic transport. The nuclear localization of some
viral and cellular proteins is facilitated by the cytoskeleton,
particularly microtubules, by mediating their perinuclear accu-
mulation [51]. For example, Roth et al. found evidence for the
involvement of microtubules in the nuclear import of some
proteins, such as the cancer-related proteins p53, pRB, and
PTHrP, but not others [52,53]. Similarly, microtubules play a role
in the nuclear import of STAT1 and STAT5B [54,55]. There is
substantial evidence that the role of microtubules in nucleocyto-
plasmic trafficking of cellular proteins is mediated by dynein;
examples include the nuclear import of the mineralocorticoid
receptor, STAT5B, and NFkB [55,56,57,58]. The role of the
cytoskeleton and dynein in the nucleocytoplasmic transport of viral
components is also very well documented, and different viral
proteins interact with different dynein subunits, including
DYNLT1 [59,60,61,62].
DYNLT1 is also implicated in functions independent of the
cytoplasmic dynein complex [63]. DYNLT1 was shown to
mediate neuritogenesis during hippocampal neuronal develop-
ment in a dynein-independent manner [64]. It was also identified
as an activator of G-protein signaling in association with several
receptor proteins like the Trk neurotrophin receptor, bone
morphogenetic receptor type II and the parathyroid hormone
receptors [65,66,67,68]. DYNLT1 also interacts with Lfc, a
guanine nucleotide exchange factor in a phosphorylation depen-
dent manner to regulate neurogenesis [69,70]. RP3, a dynein light
chain subunit, localizes to the nucleus and is involved in
transcriptional regulation [71]. Localization studies showed a
sub-population of DYNLT1 in the nucleus [63]. We have also
observed a population of nuclear DYNLT1 (Fig. 4) and have
shown that DYNLT1 plays a role in transcriptional dysregulation
by NUP98-HOXA9 (Fig. 7).
Structural analysis showed that each DYNLT1 core contains
two a-helices followed by four b-strands [35]. We have separated
the a-helix-containing regions form the b-strand-containing
regions and found that functional interactions with NUP98-
HOXA9 or nucleoporins occurred through the b-strand region
(Fig. 6). The interactions between DYNLT1 and other compo-
nents of the dynein complex also occur through this b-stand
containing region, suggesting that the interactions of DYNLT1
with nucleoporins and with components of the dynein complex
may be mutually exclusive [36]. Thus it is possible that DYNLT1
functions within the nuclear pore complex independent of the
dynein complex. In yeast dynein light chains are integrated into
the nuclear pore complex and provide structural support to the
nuclear pore complex components [41,42]. DYNLT1 may play a
similar role in the mammalian nuclear pore complex.
Our data suggest a role for DYNLT1 in leukemogenesis.
NUP98-HOXA9 is a leukemogenic oncoprotein that acts as an
aberrant transcription factor [12,13,17,19]. The N-terminal FG
repeat region of NUP98-HOXA9 has been implicated in the
ability of NUP98-HOXA9 to dysregulate transcription and to
cause leukemic transformation [12,13,14,19]. Here we have
shown that DYNLT1 interacts with this FG repeat region and
that depletion of DYNLT1 impairs the ability of NUP98-HOXA9
to dysregulate transcription and to induce proliferation of primary
human CD34+ cells (Figs. 7 and 8). These data suggest that
DYNLT1 cooperates with NUP98-HOXA9 in leukemogenesis.
Indeed, a study in a leukemia mouse model showed that the
axonemal dynein light chain 4 (Dnalc4) and dynactin 3 (Dctn3)
cooperate with NUP98-HOXA9 in mediating leukemogenesis
[72]. Dynein components have also been implicated in the
pathogenesis of other tumors. For example, upregulation of
DYNLL1 was shown to promote cell proliferation and tumori-
genesis by stimulating cyclin-dependent kinase 2 activity in
hormone-responsive cancers [73,74]. Similarly, dynein light chain
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DYNLRB1 is upregulated in patients with hepatocellular carci-
noma [75].
To summarize, we have identified DYNLT1 as a component of
the nuclear pore complex and a novel interacting partner for the
oncoprotein NUP98-HOXA9 that cooperates with it in transcrip-
tional deregulation and in the induction of proliferation of primary
human CD34+ hematopoietic precursors. These data establish a
direct link between dynein and the nuclear pore complex and
suggest a role for DYNLT1 in the pathogenesis of AML caused by
NUP98 fusions. Further studies are needed to determine the
function of DYNLT1 at the nuclear pore complex, its role in
nucleocytoplasmic transport, and the mechanisms by which it
contributes to transcriptional dysregulation by oncogenic NUP98
fusions.
Supporting Information
Figure S1 Purification of Rabbit anti-DYNLT1 antibody
from serum. K562 cell lysates were subjected to SDS-PAGE
and transferred to Hybond C-extra nitrocellulose membrane.
Membrane strips were subjected to immunoblotting with 1:2000
dilutions of the indicated serum fractions and eluates. Lane 1: anti
–DYNLT1 Rabbit Serum. Lane 2: anti –DYNLT1 Rabbit
Serum/Bacterial lysate Flow through. Lane 3. Anti –DYNLT1
Rabbit Serum/DYNLT1 (N)-Affigel Beads Flow through. Lanes
4–11: Purified fractions 1–8 (0.1 M Glycine).
(TIF)
Figure S2 Densitometric quantification of shRNA-me-
diated DYNLT1 knockdown. K562 cells were transfected with
a firefly luciferase construct driven by the KBTBD10 promoter
with either empty vector or vector expressing NUP98-HOXA9. In
addition, the transfections included either empty vector, or vector
expressing non-specific shRNA, or vectors expressing 2 different
DYNLT1 shRNAs. The intensities of the DYNLT1 bands in Fig. 7
were quantified using Chemidoc Quantity One software (BioRad).
The DYNLT1 band intensities are shown as % of the empty
vector control in lane 1.
(TIF)
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